- Premium Stock Alerts
- Posts
- Pre-Market Gainers You Need to See!
Pre-Market Gainers You Need to See!
Noor Saba
March 21, 2024
Don’t want emails from us anymore? Click here to unsubscribe
Hello Part-time Trader…👋
Premium Stock Alerts is here with your pre-market cheat sheet. 🚀 Unusual movers, 🎞️ pre-market movers, and 💥 upcoming FDA events – we've got it all!
Happening Today
✓ 08:30 AM ET – Initial Jobless Claims
✓ 08:30 AM ET – Philadelphia Fed Manufacturing Index (Mar)
✓ 09:45 AM ET – S&P Global US Manufacturing PMI (Mar)
✓ 09:45 AM ET – S&P Global Services PMI (Mar)
✓ 10:00 AM ET – Existing Home Sales (Feb)
Sponsored
JUST RELEASED: Top 10 Stocks to Own Now
At MarketBeat, we put thousands of stocks through the ringer... analyzing their fundamentals, earnings, growth potential, management and more. These 10 stocks rose to the top.
Some are delivering stellar earnings... others are at the forefront of an explosive trend... others dominate their industry. All offer tremendous opportunity no matter what the market does. Yours FREE
Get the full list with our detailed analysis in a new report, "The 10 Best Stocks to Own in 2024".
Daily Quote
The market can remain irrational longer than you can remain solvent. - Keynes
PREMARKET SNAPSHOT 📈
Green across the board for Stock Futures! NASDAQ 100 takes the lead with a pre-market jump of 1.25%.
S&P500$5,224.62 ⬆️ 0.89% | Dow$39,512.13 ⬆️ 1.03% | NASDAQ$16,369.41 ⬆️ 1.25% |
Sponsored
My #1 Coin is...
You're looking for the #1 Coin to invest in... Am I right? Then check out this special $3 report.
Inside, you'll find the name of the coin, how to invest, and what to expect.
Don't miss your chance...
All the details are on the next page.
SECTOR SNAPSHOT ✨
Sector watch: Consumer Discretionary surges ahead, while Health Care takes a breather. Overall, the market shows modest gains.
NAME | PRICE | %CHANGE |
|---|---|---|
Consumer Discretionary | 1,477.59 | +1.45% 🟢 |
Consumer Staples | 810.99 | +0.23% 🟢 |
Energy | 703.32 | -0.09% 🔴 |
Financials | 692.10 | +1.24% 🟢 |
Health Care | 1,697.30 | -0.23% 🔴 |
Industrials | 1,053.40 | +1.21% 🟢 |
Materials | 576.94 | +0.98% 🟢 |
Real Estate | 244.73 | +0.39% 🟢 |
Information Technology | 3,847.26 | +1.15% 🟢 |
Communication Services | 284.52 | +1.26% 🟢 |
Utilities | 324.55 | +0.13% 🟢 |
Unusual Volume
📈 Jaguar Health Inc (JAGX) jumped 15.97% to $0.08 on a whopping 208.3 million shares traded after announcing that it has signed a deal with Turkish pharmaceutical firm Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret, A.S. for the exclusive license and commercialization of Jaguar's FDA-approved plant-based drug crofelemer.
📈 Investors went wild, sending BYND Cannasoft Enterprises Inc (BCAN) stock soaring 2.50% to $0.02 on a massive volume of 187.24 million shares.
📈 Abnormal activity shook SMX (Security Matters) Plc (SMX), pushing it up 26.13% to $0.18 on a whopping 98.54 million shares traded after the company announced a pilot program with PepsiCo to combat counterfeiting.
📈 Oblong Inc (OBLG) stock recently closed 19.78% upper at $0.16 on substantial volume of 87.96 million shares. This unusual activity came after the company granted 180-Day extension by Nasdaq to regain compliance with Bid Price Rule.
📈 Etao International Co Ltd. (ETAO) increase by 91.76% in a single trading session, with abnormally high trading volume of 59.55 million shares following the revelation of plans for a reverse stock split.
Sponsored
Add This Little-Known "EV" Battery Metals Stock to Your Watchlist
The EV battery market is booming, set to hit $276 billion by 2030, driving up demand for lithium and cobalt for new batteries. Amidst this growth, one under-the-radar company stands out, not just for its strategic position in the lithium-rich regions of the Western United States but also for its unique listing on both the US and Canadian markets. Immediately add this company to your watchlist.
Click Now to Reveal Ticker
Premarket Movers
CURI (CuriosityStream Inc.): Surges 33.36% on 1.54M shares traded, following release of its fourth quarter and full Year 2023 financial results and initiatiing of dividend program.
MU (Micron Technology, Inc.): Gains 17.82% on 402.20K shares, after declaring results for the second quarter of fiscal 2024.
XFOR (X4 Pharmaceuticals, Inc.): Jumps 11.76% on 220.56K shares, in response to financial results for the fourth quarter and full year ended December 31, 2023.
Pre Market Gainers | Pre Market Change | Pre Market Volume |
|---|---|---|
KAVL | +57.14% | 2.69M |
JOAN | +7.11% | 2.00M |
CURI | +33.36% | 1.54M |
FSR | +8.19% | 1.53M |
TROO | +14.72% | 945.98K |
GOEV | +19.65% | 641.46K |
WISA | +4.93% | 413.05K |
MU | +17.82% | 402.20K |
LICY | +3.97% | 350.43K |
XFOR | +11.76% | 220.56K |
Sponsored
Unlock Your Future Wealth with AI Stocks Now!
Missed out on Amazon or Apple? AI is your next big chance! Dive into the future with our FREE report on 3 Undiscovered AI Stocks set to soar. Don't let this opportunity slip away and shape your investment destiny today.
Get Your Free AI Stocks Report Now!
Important FDA
Recently Announced
Orchard Therapeutics plc (ORTX) achieved FDA approval for its gene therapy, OTL-200, branded Lenmeldy, to treat metachromatic leukodystrophy in children, marking a significant milestone in pediatric healthcare, announced on March 18, 2024.
OptiNose Inc. (OPTN) obtained FDA approval on March 15, 2024, for XHANCE nasal spray, broadening its application to treat chronic rhinosinusitis in adults.
Upcoming this Week
Merck & Co Inc. (MRK) awaits FDA decision on Sotatercept for pulmonary arterial hypertension in adults, seeking improved treatment options.
Akebia Therapeutics, Inc. (AKBA) anticipates the outcome of its Vadadustat NDA resubmission on March 27, 2024, aiming to address anemia in CKD patients undergoing dialysis.
Esperion Therapeutics (ESPR) eagerly awaits FDA decision on NEXLIZET on March 31, 2024, focusing on cardiovascular risk reduction and expanding indications for LDL-C lowering, aiming to enhance patient outcomes.
🎁 Looking for More? Check out these complementary newsletters for diverse perspectives:
|
|
Happy investing,
Maeve Grace
Editor In Cheif
Premium Trade Alerts
Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.
Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.
Reply